4.3 Article

Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis

期刊

ANTICANCER RESEARCH
卷 39, 期 5, 页码 2277-2287

出版社

INT INST ANTICANCER RESEARCH
DOI: 10.21873/anticanres.13344

关键词

Mammary carcinoma; mammary epithelium; micro-environment; orthotopic tumor model; triple-negative breast cancer

类别

资金

  1. National Institute of General Medical Sciences, NIH [P20GM103499]
  2. USC School of Medicine Research and Development Fund
  3. MOHESR-Iraqi scholarship
  4. SPARC
  5. Canadian Institutes of Health [142353]
  6. USC Science Undergraduate Research Fellowship
  7. USC Magellan Scholar Award
  8. USC School of Medicine Research Program for Medical Students
  9. [R01CA218578]
  10. [P01AT003961-8455]

向作者/读者索取更多资源

Background: Low success rates in oncology drug development are prompting re-evaluation of preclinical models, including orthotopic tumor engraftment. In breast cancer models, tumor cells are typically injected into mouse mammary fat pads (MFP). However, this approach bypasses the epithelial microenvironment, potentially altering tumor properties in ways that affect translational application. Materials and Methods: Tumors were generated by mammary intraductal (MIND) engraftment of 4T1 carcinoma cells. Growth, histopathology, and molecular features were quantified. Results: Despite growth similar to that of 4T1 MFP tumors, 4T1 MIND tumors exhibit distinct histopathology and increased metastasis. Furthermore, >6,000 transcripts were found to be uniquely up-regulated in 4T1 MIND tumor cells, including genes that drive several cancer hallmarks, in addition to two known therapeutic targets that were not up-regulated in 4T1 MFP tumor cells. Conclusion: Engraftment into the epithelial microenvironment generates tumors that more closely recapitulate the complexity of malignancy, suggesting that intraductal adaptation of orthotopic mammary models may be an important step towards improving outcomes in preclinical drug screening and development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据